Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 18.55
+0.40 (2.20%)
Oct 20, 2026, 1:19 PM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 548.81 million as of October 20, 2026. It is the 38,905th most valuable company in the world and the 2,264th biggest in Taiwan. Its market cap has decreased by 23.66% in one year.
Market Cap
548.81M
Enterprise Value
510.58M
Revenue
207.17M
Global Rank
Country Rank
#2,264 Taiwan
PE Ratio
28.61
ChartMarket Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 548.81M, a decrease of -71.72%. That is a compound annual growth rate of -18.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 548.81M | -11.24% |
| Dec 31, 2025 | 618.33M | -2.69% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.20B |
| InnoPharmax | 1.13B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 1.07B |
| Anxo Pharmaceutical | 902.23M |
| DV Biomed | 871.69M |
| Original BioMedicals | 796.21M |
| Mediera | 788.97M |